Proteinuria
BASICS
- Definition: Proteinuria = urinary protein excretion >150 mg/day
- Nephrotic-range: ≥3.5 g/day (adults); >1,000 mg/m²/day (children)
- Pediatrics: Normal up to 100 mg/m²/day (neonates up to 300 mg/m²/day)
- Pregnancy: >20 weeks—think preeclampsia/eclampsia; <20 weeks—suggests underlying renal disease
EPIDEMIOLOGY
- Prevalence varies by definition; up to 10% in school-aged children
ETIOLOGY & PATHOPHYSIOLOGY
- Normal filtration: ≤150 mg/day (mostly albumin ~20 mg)
- Glomerular proteinuria: Increased capillary permeability (primary: minimal-change, membranous, FSGS, MPGN, IgA; secondary: DM, HTN, lupus, amyloid, infection, malignancy, drugs)
- Tubulointerstitial: Impaired proximal tubular reabsorption (e.g., NSAIDs, aminoglycosides, ATN, Fanconi, interstitial nephritis, toxins)
- Overflow: Excess filtered LMW proteins (e.g., multiple myeloma, hemoglobinuria, myoglobinuria)
- Benign/transient: Fever, exercise, orthostatic (postural), dehydration, stress
PREVENTION
- Control weight, BP, and glucose to lower risk of proteinuric kidney disease
ASSOCIATED CONDITIONS
- Nephrotic syndrome, glomerulonephritis, CKD
DIAGNOSIS
History
- Frothy/foamy urine, swelling, hematuria, recent infection, changes in urine output, UTI, DM, CHF, lupus, pregnancy symptoms (headache, visual changes, swelling)
Physical Exam
- Vitals (BP, temp)
- Weight, peripheral/periorbital edema
- Abdominal/CVA tenderness, ascites, heart/lung for CHF
Initial Labs/Testing
- Urinalysis (UA): Initial screen (sensitive for albumin, not LMW proteins)
- 1+ = 30 mg/dL, 2+ = 100 mg/dL, 3+ = 300 mg/dL, 4+ = 1,000 mg/dL
- False +: alkaline, concentrated urine, hematuria, drugs
- False -: dilute urine, low albumin, non-albumin proteins
- If trace–2+: Repeat UA to rule out transient causes
- If persistent/3+–4+: Quantify with spot urine protein:creatinine ratio (P/C) (preferred over 24-hr collection)
- P/C ratio (mg/mg or g/g): Correlates to g/24h
- Orthostatic: <0.3 supine, >0.3 upright
- If P/C >0.3: Further labs: CBC, LFT, lipids, ferritin, ESR, coags, autoimmune serologies, viral (HIV, hepatitis), complement, SPEP/UPEP (MM), antiphospholipase A2R (membranous)
- Imaging: Renal US if persistent/proteinuria unexplained
Special Populations
- Pregnancy: Proteinuria >20 weeks—screen for preeclampsia (BP, platelets, LFTs)
TREATMENT
General
- Treat underlying disease
- BP goal (diabetic/nondiabetic): ≤140/90 mm Hg
- If albuminuria: ≤130/80; if >1g/24h: ≤125/75
- Proteinuria goal: <0.5 g/day
Lifestyle
- Protein restriction: 0.8 g/kg/day if GFR <30, DM or not
- Salt restriction: <2 g/day sodium
- Fluid restriction: urine output <2 L/day
- Smoking cessation
- Weight loss
- Supine rest (↓proteinuria by up to 50%)
- Limit severe exertion
Medications
First Line
- ACEi: Titrate to max tolerated, even if normotensive (preferred)
- ARBs: If ACEi not tolerated; do NOT combine ACEi+ARB
- Loop diuretics: For edema and BP/proteinuria
- Continue ACEi/ARB up to 30% rise in creatinine
Second Line
- β-Blockers: Cardio- and renoprotective
- Non-dihydropyridine CCBs: (verapamil/diltiazem) if additional antiproteinuric effect needed
- Aldosterone antagonists: Spironolactone, eplerenone
Avoid
- NSAIDs: Though antiproteinuric, nephrotoxic and not recommended
Nephrotic Syndrome
- Corticosteroids: For steroid-responsive disease (e.g., minimal change, especially in children)
- Anticoagulation: Consider if nephrotic-range proteinuria (risk of thrombosis)
ONGOING CARE
- Serial BP, UA, renal function monitoring
- Diet: Na+ <2 g/day, calories to normalize BMI, fat <30% total
- Refer to nephrology if impaired GFR, nephrotic range, or uncertain etiology
PROGNOSIS
- Transient/orthostatic proteinuria: benign
- Persistent: depends on cause; higher levels predict CKD progression, MI, mortality
- Nephrotic-range: risk hypercholesterolemia, hypercoagulability, infection
COMPLICATIONS
- Progression to CKD
- Hypercholesterolemia
- Thromboembolism
- Infection (especially with nephrotic syndrome)
ICD-10 CODES
- R80.9 Proteinuria, unspecified
- R80.2 Orthostatic proteinuria, unspecified
- R80.1 Persistent proteinuria, unspecified
CLINICAL PEARLS
- Transient and orthostatic proteinuria are benign
-
2 g/day proteinuria: likely glomerular—nephrology consult
- Degree of proteinuria correlates with CKD progression
- First-line therapy for persistent proteinuria is high-dose ACE inhibitor